Kernel’s Brain-Imaging Helmet Approved For Clinical Trial On Patients Using Ketamine (Forbes):
The U.S. Food and Drug Administration has approved a clinical trial using a neuroimaging helmet made by Los Angeles-based Kernel to track what happens in the brain when a human takes a psychedelic dose of ketamine. [Read more…] about FDA-approved, Cybin-sponsored clinicial trial to measure ketamine’s impact on the brain via Kernel Flow neuroimaging helmet